Chester County News and Community Website
EXTON, PA — Innovative Solutions & Support, Inc. (Nasdaq: ISSC) reported a strong financial performance for the second quarter of fiscal 2025, highlighted by a 104% increase in revenue to …
IS&S Posts 104% Revenue Growth in Q2 2025 Read More
WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) has released its financial results for the first quarter of 2025, along with key updates from its clinical development programs for QTORIN™ …
Palvella Therapeutics Reports Q1 2025 Financials and Clinical Progress Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced significant progress in the first quarter of 2025, reporting $3.4 million in revenue from YCANTH. This figure reflects a …
Verrica Pharmaceuticals Reports Record Q1 Revenue and Advancements in Pipeline Read More
MALVERN, PA — Cantaloupe, Inc. (Nasdaq: CTLP), a leader in payment and self-service technology, has announced its financial results for the third quarter of fiscal year 2025, ended March 31, …
Cantaloupe, Inc. Reports Robust Third-Quarter Fiscal 2025 Financial Results Read More
VALLEY FORGE, PA — UGI Corporation (NYSE: UGI) has announced its financial results for the second quarter of fiscal 2025, reflecting robust performance and raising its adjusted EPS guidance for …
UGI Corporation Reports Strong Q2 Fiscal 2025 Results and Raises Guidance Read More
WAYNE, PA — Trinseo (NYSE: TSE) has announced its financial results for the first quarter of 2025, reflecting both challenges and strategic gains. The quarter ended with net sales of …
Trinseo Reports Q1 2025 Financial Results and Prepares for Q2 Challenges Read More
EXTON, PA — Bentley Systems, Incorporated (Nasdaq: BSY) has announced robust results for the first quarter of 2025, showcasing solid growth in revenues, profitability, and recurring revenues despite global market …
Bentley Systems Reports Strong Q1 2025 Financial Performance Read More
MALVERN, PA — Endo, Inc. (OTCQX: NDOI) announced its financial results for the first quarter ended March 31, 2025, highlighting solid growth in the Branded Pharmaceuticals segment and the reaffirmation …
Endo, Inc. Reports First-Quarter 2025 Financial Results Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has reported its first-quarter 2025 financial results and shared updates on its growing pipeline of gene therapy treatments aimed at combating significant unmet …
Ocugen Reports Progress in Q1 2025 with Advancements in Gene Therapy Read More
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) reported a strong start to 2025, with first-quarter revenue reaching $18.5 million, a 12% increase compared to the same period last year …
TELA Bio Reports Q1 2025 Growth and Product Expansion Read More